The PRMT5-splicing axis is a critical oncogenic vulnerability that regulates detained intron splicing
Authors:
- Colin E. FowlerCFColin E. Fowler
- Natalie A. O’hearnNONatalie A. O’hearn
- Paul L. BoutzPBPaul L. Boutz
- Jacqueline A. LeesJLJacqueline A. Lees
Preprint
Abstract
Summary: Protein arginine methyltransferase 5 (PRMT5) is a promising cancer target, yet it’s unclear which PRMT5 roles underlie this vulnerability. Here, we establish that PRMT5 inhibition induces a special class of unspliced introns, called detained introns (DIs). To interrogate the impact of DIs, we depleted CLNS1A, a PRMT5 cofactor that specifically enables Sm protein methylation. We found that many, but not all, cell lines are CLNS1A-dependent and established that loss of viability is linked to loss of Sm protein methylation and DI upregulation. Finally, we discovered that PRMT5-regulated DIs, and the impacted genes, are highly conserved across human, and also mouse, cell lines but display little interspecies conservation. Despite this, human and mouse DIs have convergent impacts on proliferation by affecting essential components of proliferation-regulating complexes. Together, these data argue that the PRMT5-splicing axis, including appropriate DI splicing, underlies cancer’s vulnerability to PRMT5 inhibitors.Keywords
All Related Versions
- Published version: iScience, 28 (7), 112965.
This publication has 50 references indexed in Scilit:
- Molecular basis for substrate recruitment to the PRMT5 methylosomeMolecular Cell, 2021
- PRMT5 Modulates Splicing for Genome Integrity and Preserves Proteostasis of Hematopoietic Stem CellsCell Reports, 2019
- PRMT5 Regulates DNA Repair by Controlling the Alternative Splicing of Histone-Modifying EnzymesCell Reports, 2018
- Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant GliomaCancer Cell, 2017
- A Detailed Protocol for Subcellular RNA Sequencing (subRNA‐seq)Current Protocols in Molecular Biology, 2017
- A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL modelsNature Chemical Biology, 2015
- The PRMT5 arginine methyltransferase: many roles in development, cancer and beyondCellular and Molecular Life Sciences, 2015
- Suppression of lung adenocarcinoma progression by Nkx2-1Nature, 2011
- Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pIClnCurrent Biology, 2001
- Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B′ and the Sm-like protein LSm4, and their interaction with the SMN proteinRNA, 2001